Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_583c4749a571991a5129c38c71f4f067 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-524 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-526 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
filingDate |
2022-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8effa193ae00731bbad0430443a632f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f68ecf52bcc3e1f9fb2ed27cc1e4719 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f667e03ee08f308cc093ec3db9c18719 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cab3c40c63d8574fa469fec813c7aa35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aefaedbd66b291cf7f12af48d2ddb0aa |
publicationDate |
2022-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022219058-A1 |
titleOfInvention |
Fc-derived polypeptides |
abstract |
The present disclosure pertains to polypeptides comprising a transmembrane domain and an FcRn binding site (e.g., a modified Fc domain) and nanovesicles (e.g, extracellular vesicles (EVs) and hybridosomes) comprising such polypeptides. Said polypeptides can facilitate isolation and purification of nanovesicles comprising such polypeptides. The polypeptides and nanovesicles can be used in therapeutic and/or diagnostic applications. Also provided are nucleic acids and expression vectors encoding such polypeptides as well as cells expressing said polypeptides. Further provided are methods for producing nanovesicles comprising such polypeptides and methods for purifying these nanovesicles. Compositions comprising such polypeptides or nanovesicles as well as their uses are also described. |
priorityDate |
2021-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |